Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
75,239 questions in 5,342 reviews
current versionsNo studies 15,213 · 20.2%Ungraded 10,323 · 13.7%Very low 17,528 · 23.3%Low 17,951 · 23.9%Moderate 11,190 · 14.9%High 3,034 · 4%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Pain ‐ not measured · patients with chronic (>12 months) lateral elbow pain Surgery for lateral elbow pain (2011) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events ‐ not measured · patients with chronic (mean 23 months) lateral elbow pain Surgery for lateral elbow pain (2011) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Pain ‐ not reported · patients with chronic (>6 months) lateral elbow pain Surgery for lateral elbow pain (2011) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Disabilty ‐ not measured · patients with chronic (>6 months) lateral elbow pain Surgery for lateral elbow pain (2011) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events ‐ not measured · patients with chronic (>6 months) lateral elbow pain Surgery for lateral elbow pain (2011) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Disability DASH scale. Scale from: 0 to 100. ( · patients with chronic (>12 months) lateral elbow pain Surgery for lateral elbow pain (2011) · Cochrane | no estimate extracted | 1 study · 47 participants | Low |
Intervention NR Adverse events ‐ not measured · patients with chronic (>12 months) lateral elbow pain Surgery for lateral elbow pain (2011) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Pain‐ short term VAS scale. Scale from: 0 to 10. ( · patients with lateral elbow pain Surgery for lateral elbow pain (2011) · Cochrane | no estimate extracted | 1 study · 24 participants | Moderate |
Intervention NR Pain‐ long term VAS. Scale from: 0 to 10. ( · patients with lateral elbow pain Surgery for lateral elbow pain (2011) · Cochrane | no estimate extracted | 1 study · 24 participants | Low |
Intervention NR Disability Mayo Elbow Performance. Scale from: 0 to 100. ( · patients with lateral elbow pain Surgery for lateral elbow pain (2011) · Cochrane | no estimate extracted | 1 study · 24 participants | Low |
Intervention NR Adverse events ‐ not reported · patients with lateral elbow pain Surgery for lateral elbow pain (2011) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Pain ‐ not reported · patients with chronic (mean 23 months) lateral elbow pain Surgery for lateral elbow pain (2011) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Disability ‐ not measured · patients with chronic (mean 23 months) lateral elbow pain Surgery for lateral elbow pain (2011) · Cochrane | no estimate extracted | NR | No studies |
ORS ≤ 270 mOsm/L (glucose‐based) vs ORS ≥ 310 mOsm/L (glucose‐based) Death · patients with cholera Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions (2011) · Cochrane | no estimate extracted | 2 studies · 121 participants | Ungraded |
ORS ≤ 270 mOsm/L (rice‐based) vs ORS ≥ 310 mOsm/L (glucose‐based) Symptomatic hyponatraemia · patients with cholera Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions (2011) · Cochrane | no estimate extracted | 1 study · 39 participants | Ungraded |
ORS ≤ 270 mOsm/L (rice‐based) vs ORS ≥ 310 mOsm/L (glucose‐based) Severe biochemical hyponatraemia(serum sodium < 125 mmol/L) · patients with cholera Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions (2011) · Cochrane | RR 0.35 [0.02, 8.1] | 2 studies · 102 participants | Low |
ORS ≤ 270 mOsm/L (rice‐based) vs ORS ≥ 310 mOsm/L (glucose‐based) Biochemical hyponatraemia(serum sodium < 130 mmol/L) · patients with cholera Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions (2011) · Cochrane | RR 0.66 [0.26, 1.69] | 2 studies · 102 participants | Low |
ORS ≤ 270 mOsm/L (rice‐based) vs ORS ≥ 310 mOsm/L (glucose‐based) Duration of diarrhoea(in hours) · patients with cholera Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions (2011) · Cochrane | no estimate extracted | 2 studies · 102 participants | Low |
ORS ≤ 270 mOsm/L (rice‐based) vs ORS ≥ 310 mOsm/L (glucose‐based) Stool output in first 24 hours after admission or randomization · patients with cholera Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions (2011) · Cochrane | no estimate extracted | 0 studies · 0 participants | Ungraded |
ORS ≤ 270 mOsm/L (glucose‐based) vs ORS ≥ 310 mOsm/L (glucose‐based) Need for unscheduled intravenous infusion · patients with cholera Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions (2011) · Cochrane | RR 0.86 [0.66, 1.12] | 5 studies · 616 participants | Moderate |
ORS ≤ 270 mOsm/L (glucose‐based) vs ORS ≥ 310 mOsm/L (glucose‐based) Symptomatic hyponatraemia · patients with cholera Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions (2011) · Cochrane | no estimate extracted | 5 studies · 620 participants | Ungraded |
ORS ≤ 270 mOsm/L (glucose‐based) vs ORS ≥ 310 mOsm/L (glucose‐based) Biochemical hyponatraemia (serum sodium < 130 mmol/L) · patients with cholera Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions (2011) · Cochrane | RR 1.67 [1.09, 2.57] | 4 studies · 465 participants | Moderate |
ORS ≤ 270 mOsm/L (glucose‐based) vs ORS ≥ 310 mOsm/L (glucose‐based) Severe biochemical hyponatraemia (serum sodium < 125 mmol/L) · patients with cholera Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions (2011) · Cochrane | RR 1.58 [0.62, 4.04] | 4 studies · 465 participants | Low |
ORS ≤ 270 mOsm/L (glucose‐based) vs ORS ≥ 310 mOsm/L (glucose‐based) Duration of diarrhoea (in hours) · patients with cholera Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions (2011) · Cochrane | no estimate extracted | 6 studies · 683 participants | Moderate |
ORS ≤ 270 mOsm/L (glucose‐based) vs ORS ≥ 310 mOsm/L (glucose‐based) Stool output in first 24 hours after admission or randomization · patients with cholera Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions (2011) · Cochrane | no estimate extracted | 4 studies · 581 participants | Moderate |
ORS ≤ 270 mOsm/L (rice‐based) vs ORS ≥ 310 mOsm/L (glucose‐based) Death · patients with cholera Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions (2011) · Cochrane | no estimate extracted | 0 studies · 0 participants | Ungraded |
ORS ≤ 270 mOsm/L (rice‐based) vs ORS ≥ 310 mOsm/L (glucose‐based) Need for unscheduled intravenous infusion · patients with cholera Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions (2011) · Cochrane | no estimate extracted | 0 studies · 0 participants | Ungraded |
Intervention NR Catheter‐related blood stream infection (CRBI) Same organism recovered from catheter tip and blood culture · patients with central venous catheters Gauze and tape and transparent polyurethane dressings for central venous catheters (2011) · Cochrane | OR 4.19 [1.02, 17.23] | 4 studies · 337 participants | Low |
Intervention NR Exit‐site infection Laboratory testing · patients with central venous catheters Gauze and tape and transparent polyurethane dressings for central venous catheters (2011) · Cochrane | OR 1.78 [0.62, 5.08] | 3 studies · 265 participants | Low |
Intervention NR Positive catheter culture Laboratory testing · patients with central venous catheters Gauze and tape and transparent polyurethane dressings for central venous catheters (2011) · Cochrane | OR 0.74 [0.27, 2.09] | 2 studies · 138 participants | Low |
Day hospital vs Inpatient Feasibility and engagement: lost to · patients with acute psychiatric disorders Day hospital versus admission for acute psychiatric disorders (2011) · Cochrane | RR 0.94 [0.82, 1.08] | 5 studies · 1694 participants | Moderate |
Day hospital vs Inpatient Extent of hospital care: 1. duration of index admission · patients with acute psychiatric disorders Day hospital versus admission for acute psychiatric disorders (2011) · Cochrane | no estimate extracted | 4 studies · 1582 participants | Moderate |
Day hospital vs Inpatient Extent of hospital care: 3. duration of day patient care (adjusted days/month) · patients with acute psychiatric disorders Day hospital versus admission for acute psychiatric disorders (2011) · Cochrane | no estimate extracted | 3 studies · 465 participants | Very low |
Day hospital vs Inpatient Extent of hospital care: 5. readmitted to in/day patient care after discharge · patients with acute psychiatric disorders Day hospital versus admission for acute psychiatric disorders (2011) · Cochrane | RR 0.91 [0.72, 1.15] | 5 studies · 667 participants | Very low |
Day hospital vs Inpatient Unemployed (at end of study) · patients with acute psychiatric disorders Day hospital versus admission for acute psychiatric disorders (2011) · Cochrane | RR 0.81 [0.67, 0.97] | 2 studies · 320 participants | Low |
Day hospital vs Inpatient Quality of life: average overall role score ‐ at 12 months MANSA ‐ Manchester Short Assessment of Quality of Life · patients with acute psychiatric disorders Day hospital versus admission for acute psychiatric disorders (2011) · Cochrane | no estimate extracted | 1 study · 1117 participants | Moderate |
Day hospital vs Inpatient Treatment satisfaction: average overall role score ‐ at discharge CAT ‐ Client Assessment of Treatment · patients with acute psychiatric disorders Day hospital versus admission for acute psychiatric disorders (2011) · Cochrane | no estimate extracted | 1 study · 1117 participants | Moderate |
Combination fluticasone/salmeterol vs budesonide/formoterol Participants experiencing exacerbations requiring oral steroid treatment · Patients with chronic asthma in adults and children Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic… (2011) · Cochrane | OR 0.89 [0.74, 1.07] | 4 studies · 4949 participants | Moderate |
Combination fluticasone/salmeterol vs budesonide/formoterol Participants experiencing exacerbations requiring admission to hospital · Patients with chronic asthma in adults and children Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic… (2011) · Cochrane | OR 1.29 [0.68, 2.47] | 4 studies · 4879 participants | Moderate |
Combination fluticasone/salmeterol vs budesonide/formoterol Asthma‐related serious adverse event · Patients with chronic asthma in adults and children Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic… (2011) · Cochrane | OR 1.47 [0.75, 2.86] | 3 studies · 4054 participants | Moderate |
Combination fluticasone/salmeterol vs budesonide/formoterol Mortality · Patients with chronic asthma in adults and children Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic… (2011) · Cochrane | no estimate extracted | 5 studies · 4819 participants | Low |
Combination fluticasone/salmeterol vs budesonide/formoterol Withdrawals (adverse events) · Patients with chronic asthma in adults and children Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic… (2011) · Cochrane | OR 0.94 [0.6, 1.46] | 5 studies · 5082 participants | Moderate |
Any Psychosocial intervention plus pharm vs pharm standard Retention in treatment Objective · patients with treatment of opioid dependence Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for… (2011) · Cochrane | RR 1.02 [0.97, 1.07] | 26 studies · 2582 participants | High |
Any Psychosocial intervention plus pharm vs pharm standard Opioid abstinence objective · patients with treatment of opioid dependence Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for… (2011) · Cochrane | RR 1.19 [0.91, 1.56] | 7 studies · 667 participants | High |
Any Psychosocial intervention plus pharm vs pharm standard Number of participants still in treatment at the end of · patients with treatment of opioid dependence Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for… (2011) · Cochrane | RR 0.9 [0.77, 1.07] | 3 studies · 250 participants | High |
Any Psychosocial intervention plus pharm vs pharm standard Number of participants abstinent at the end of · patients with treatment of opioid dependence Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for… (2011) · Cochrane | RR 1.15 [0.98, 1.36] | 3 studies · 181 participants | High |
Any Psychosocial intervention plus pharm vs pharm standard Compliance objective · patients with treatment of opioid dependence Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for… (2011) · Cochrane | no estimate extracted | 3 studies · 685 participants | Moderate |
Transfer from incubator to cot at lower vs higher body weight Daily weight gain (g/kg/day) · patients with preterm infants Transfer of preterm infants from incubator to open cot at lower versus higher body weight (2011) · Cochrane | no estimate extracted | 2 studies · 276 participants | High |
Transfer from incubator to cot at lower vs higher body weight Proportion of infants having at least one episode of low temperature requiring overhead heater use · patients with preterm infants Transfer of preterm infants from incubator to open cot at lower versus higher body weight (2011) · Cochrane | RR 1.43 [0.78, 2.62] | 2 studies · 276 participants | High |
Transfer from incubator to cot at lower vs higher body weight Proportion of infants having at least one episode of returning to incubator · patients with preterm infants Transfer of preterm infants from incubator to open cot at lower versus higher body weight (2011) · Cochrane | RR 1.78 [0.77, 4.08] | 3 studies · 336 participants | Moderate |